Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Du

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|May 16, 2022
Pathogenic or benign?Peter P Du, Katherine Liu, Michael C Bassik, et al.
Nature Biotechnology|October 10, 2022
Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genomeMatthew G Durrant, Alison Fanton, Josh Tycko, et al.
Nature Communications|November 27, 2025
Reduced Cas9 transgene silencing by incorporation of intron sequencesSophia Arana, Peter P Du, Alun Vaughan-Jackson, et al.
Immunity|January 26, 2021
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinomaJuan Dubrot, Sarah Kate Lane-Reticker, Emily A Kessler, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasionSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Nature Biotechnology|November 2, 2024
Development of compact transcriptional effectors using high-throughput measurements in diverse contextsJosh Tycko, Mike V Van, Aradhana, et al.
Nature|November 2, 2023
Glioma synapses recruit mechanisms of adaptive plasticityKathryn R Taylor, Tara Barron, Alexa Hui, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|May 16, 2022
Pathogenic or benign?Peter P Du, Katherine Liu, Michael C Bassik, et al.
Nature Biotechnology|October 10, 2022
Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genomeMatthew G Durrant, Alison Fanton, Josh Tycko, et al.
Nature Communications|November 27, 2025
Reduced Cas9 transgene silencing by incorporation of intron sequencesSophia Arana, Peter P Du, Alun Vaughan-Jackson, et al.
Immunity|January 26, 2021
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinomaJuan Dubrot, Sarah Kate Lane-Reticker, Emily A Kessler, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasionSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Nature Biotechnology|November 2, 2024
Development of compact transcriptional effectors using high-throughput measurements in diverse contextsJosh Tycko, Mike V Van, Aradhana, et al.
Nature|November 2, 2023
Glioma synapses recruit mechanisms of adaptive plasticityKathryn R Taylor, Tara Barron, Alexa Hui, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.
Pageof 2